dae. The virus is transmitted by mosquitoes or biting midges such as Culicoides spp., or both, and causes a disease characterized by abortion, stillbirth, and congenital malformation in cattle, sheep, and goats. 4, 5, 8 Outbreaks of the disease have been reported in Japan, Australia, and Israel, and the antibodies to AKAV with or without virus isolation have been detected in domestic and wild ruminants in the continents of Africa, Asia, and Oceania. 5, [9] [10] [11] Diagnosis of the disease and surveillance of virus epidemics are based on the detection of virus-specific antibodies. A 7 and hemagglutination inhibition (HI) test 2 have been developed and used for this purpose. Although the SN test is a specific and sensitive method for the detection of antibodies, it requires exclusive facilities and equipment accompanied by aseptic procedures because of the infectiousness of the virus. An indirect enzyme-linked immunosorbent assay (I-ELISA) has been developed as an alternative 3, 12 and has been recognized as a sensitive and useful method to replace SN and HI tests for the assay of a large number of samples. However, the I-ELISA is not without problems. When whole virus is used as antigen in the assay, false-positive results are frequently observed in the animal populations studied. A major factor in the false-positive reaction in I-ELISA has been the group-specific antigens used in the assay. Akabane virus consists of 3 structural proteins, G1 and G2 glycoproteins and a nucleocapsid (N) protein; of these, the N protein is a common antigen of viruses belonging to the Simbu serogroup of the genus and may cross-react with antibodies elicited by infection with other viruses belonging in the same serogroup. 6 For this reason, it would be worthwhile to develop an alternative ELISA to retain the beneficial qualities of the SN test. A previous study on neutralizing monoclonal antibody (MAb) to AKAV determined that 7 different epitopes exist on the G1 glycoprotein of AKAV. 13 In this study, a competitive enzyme-linked immunosorbent assay (C-ELISA) using these neutralizing MAbs was developed and validated for its specificity in the serodiagnosis of AKAV infection.
Akabane virus (strain OBE-1), Aino virus (AINOV, strain JaNAr 28), Ibaraki virus (IBAV, strain No. 2), Chuzan virus (CHUV, strain 31), and bluetongue virus (BTV, strain KY89) were used for this experiment. These viruses were propagated in hamster lung (HmLu-1) cells. The HmLu-1 cells were grown in Eagle's minimal essential medium a containing 0.295% tryptose phosphate broth b and 10% heat-inactivated calf serum. Medium without serum was used to propagate the viruses.
The antigen used for C-ELISA was prepared from the culture fluid of HmLu-1 cells infected with AKAV, as described previously. 13 The HmLu-1 cells were infected with AKAV at a multiplicity of infection of 0.01 and incubated at 37 C until all the cells showed a complete cytopathic effect (CPE). Culture supernatant concentrated by 0.0025 M zinc acetate precipitation was layered onto a 20% sucrose gradient in an SW 28 rotor c and centrifuged at 100,000 ϫ g for 2 hours. After the pellet was resuspended in 0.01 M TrisHCl (pH 7.4) buffer containing 0.15 M NaCl and 0.002 M ethylenediamine-tetraacetic acid, it was layered onto a continuous gradient of 10-70% (wt/vol) sucrose in an SW 40 rotor c and centrifuged at 190,000 ϫ g for 2 hours. The virus band was collected and stored at Ϫ80 C until use.
Seven MAbs to AKAV were prepared in the Clinical Virology Section, Kyushu Research Station, National Institute of Animal Health, and used for this experiment. These MAbs possessed neutralizing activity specific to AKAV and recognized different epitopes on AKAV, as described in a previous report. 13 The characteristics of the MAbs are summarized in Table 1 . All MAbs were prepared from ascites fluid of mice into whose peritoneal cavities the hybridomas were injected.
The purified AKAV was appropriately diluted with 0.05 M carbonate-bicarbonate buffer (pH 9.6), and aliquots of 50 l were dispensed into all wells of an ELISA plate. d The plate was incubated for 18 hours at 4 C and washed thrice with phosphate-buffered saline containing 0.05% Tween 20 (T/PBS). This washing process was carried out after each incubation step except the final stage in which sulfuric acid was added to stop the color reaction. The serum was diluted 5-fold with T/PBS containing 4% skim milk and added into antigen-coated wells. After incubation for 1 hour at 37 C, 50 l of optimal dilution of MAb was added to each well. The optimal dilution of MAb was determined in preliminary tests to give a maximal optical density (OD) between 1.0 and 1.5. After incubation for 1 hour at 37 C, 50 l of the optimal concentration of horseradish peroxidase-conjugated goat antibody against mouse immunoglobulins e was added to each well. After incubation for 1 hour at 37 C, 50 l of substrate solution (0.1 M citric acid, 0.2 M Na 2 HPO 4 , 0.04% o-phenylenediamine dihydrochloride, and 0.007% H 2 O 2 ) was added to each well. After 15 minutes of incubation, the reaction was stopped by adding 6 M H 2 SO 4 . The OD of each well was read using an ELISA reader f at a wavelength of 492 nm. The percentage of inhibition (PI) for each sample was calculated by the following formula:
Monoclonal antibody and conjugate were not added to the background wells.
The SN test was carried out by the microtiter method using AKAV, AINOV, and CHUV. Fifty-microliter aliquots of serial 2-fold dilutions of serum, in duplicate rows, were mixed with an equal volume of culture medium containing 100 tissue culture infective dose (50%) (TCID 50 ) of virus in flat-bottomed microplates. After incubation for 1 hour at 37 C, 0.1 ml of HmLu-1 cell suspension in GIT medium g was added to the mixture, which was then incubated for 7 days at 37 C under a 5% CO 2 atmosphere in a humidity chamber. The antibody titer was expressed as the reciprocal of the highest serum dilution at which CPE was inhibited.
To compare the competitive efficiency of MAbs, PI was measured by C-ELISA using the 7 different MAbs and compared with the SN antibody titers for sequential sera after infection with AKAV. Two Japanese black cattle were intravenously inoculated with 10 6 TCID 50 of AKAV and raised in insect-proof facilities. The sera were taken from the cattle at preinoculation and once every week after inoculation. The data from 2 cattle are shown in Fig. 1 . The SN antibody titer was 16-32 at 2 weeks after infection and remained stable for up to 7 weeks after infection. Although the PI in C-ELISA corresponded with the SN antibody titer to AKAV, the PI and its transition period differed among MAbs used as competitors. Using MAbs 13H9, 19B4, 12H6, and 15H6 as competitors in C-ELISA, the PI was about 20% at 1 week after infection and rose to above 80% at 2 weeks after infection. The PI in C-ELISA using MAbs 5B6 and 11C4 rose to above 60% at 2 weeks after infection and gradually increased up to the end of the experiment. However, the PI of MAb 13A9 was lower than that of other MAbs. It was demonstrated that the neutralizing epitopes recognized by MAbs 5B6, 13H9, 19B4, and 11C4 were well conserved in almost all the isolates of AKAV, whereas the epitopes recognized by MAbs 12H6, 15H6, and 13A9 were most mutable. 13 Among the latter MAbs, 13A9 reacted only with the strain OBE-1. The low PI of MAb 13A9 in C-ELISA might be attributed to the fact that this MAb reacts with a less dominant neutralizing antibody epitope on the virus.
The specificity of C-ELISA was tested using convalescent sera from cattle infected with 1 or more bovine arboviruses. Twenty-six bovine sera were selected from stock sera obtained from cattle that were experimentally infected with 1 or more bovine arboviruses such as AKAV, AINOV, IBAV, CHUV, and BTV. The PI in C-ELISA using 7 MAbs was compared with SN antibody titers to AKAV, AINOV, and CHUV and with group-specific antibodies to IBAV, CHUV, and BTV measured by the agar gel immunodiffusion (AGID) test. The AGID test was carried out according to the standard procedure described elsewhere. 1 The antigens used for the AGID test were prepared from the culture fluid of HmLu-1 cells infected with IBAV, CHUV, and BTV by ultrafiltration on a membrane with a molecular weight cutoff of 10,000 using a combination ultrafiltration apparatus. h The data are shown in Table 2 . The sera containing SN antibody to AKAV showed higher PI against all the MAbs in C-ELISA than the antibody-negative sera. The seropositive sera to AKAV in the SN test showed 50% or more inhibition against MAbs 13H9, 19B4, 12H6, and 15H6 in C-ELISA except for sera 717 and 800. The value of PI in C-ELISA was correlated with the SN antibody titer. However, the PI of sera in ELISA was not related to the antibody to AINOV, which belongs to the same serogroup as AKAV. Similarly, no relationship was observed between PI and the presence of the AGID antibody to viruses belonging to the Orbivirus genus. Thus, the PI value of all the MAbs in C-ELISA showed good agreement with the SN antibody titer to AKAV, and there was no cross-reactivity between the antibodies to other viruses in the Simbu serogroup of Orthobunyavirus. The fact that the AINOV antibodies did not interfere with the C-ELISA indicates that the test would be advantageous for surveillance in epidemic areas in which several arboviruses are present at the same time. The PI values of MAbs 13H9, 19B4, 2H6, and 15H6 in C-ELISA correlated well with SN antibody titers to AKAV; for instance, the sera possessing antibodies to AKAV at titers of 16 or more showed high PI values, greater than 80%. When 50% PI was adopted as a cutoff value in C-ELISA, the sera possessing SN antibody titers greater than 8 were determined to be positive except for sera numbers 717 and 800. The SN antibody-positive serum 717 showed greater than 45% PI in C-ELISA for MAbs 13H9 and 12H6. Although the SN an- tibody-negative serum 800 showed a relatively high PI value in C-ELISA, the historical data on this serum showed that the cattle had been vaccinated with the AKAV vaccine. Previous experiments for the AKAV vaccine demonstrated that the SN antibody could protect animals from AKAV infection even at a low-level SN antibody titer. 7 The inhibition of MAbs with the sera possessing low or undetectable levels of neutralizing antibodies suggested that C-ELISA would be more sensitive in detecting low-level neutralizing activity that might be protective. These results suggest that the C-ELISA potentially has a specificity in the detection of AKAV antibodies that is equal or superior to that of the SN test. The sensitivity and specificity of C-ELISA and its correlation with the SN test were evaluated using 286 field bovine sera collected in the Kagoshima prefecture, located in the southern part of Japan, where an epidemic of AKAV was observed in the summer and autumn of recent years. In this experiment, 50% PI was tentatively adopted as a cutoff value for validation in C-ELISA. An SN titer greater than or equal to 2 was considered SN test positive. The relative sensitivity, distinguishing between positive and negative relative specificity, and overall agreement between the results of SN tests and C-ELISA were calculated using the following formulas: The comparative results of SN tests and C-ELISA using 7 different competitive MAbs on 286 bovine sera are shown in Table 3 . An extremely high (Ͼ98%) relative specificity was achieved by C-ELISA when all MAbs were used. Although the relative sensitivity of C-ELISA was greater than 79% for MAbs 19B4, 12H6, and 15H6, it was lower than 76% for other MAbs. It seems that the cutoff value of 50% that was used in this experiment resulted in a decrease in relative sensitivity. The overall agreement between C-ELISA and the SN test was about 90% for MAbs 19B4, 12H6, and 15H6 among the MAbs used in this experiment. Higher sensitivities, specificities, and overall agreement were obtained using these 3 MAbs. These results suggest that the antibodies against the neutralizing epitopes corresponding to these MAbs were dominant in the sera of AKAV-infected cattle.
The performance of C-ELISA in the detection of antibodies to AKAV under the present test conditions would suggest that the test may be suitable as an alternative diagnostic method and might have the potential to replace the SN test, for which the infectious virus is needed. Furthermore, the use of MAbs in C-ELISA makes it possible to test sera from animals for which no antispecies conjugates are available. Further studies are now underway to improve the diagnostic sensitivity and specificity of this method.
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